GlassScriptPhysician profile
Scott L Smith
NPI 1336257617
$6,064.15
in general payments reported to CMS, 2019-2025
53 companies · $820 in 2025
The $820 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $591 · 2021: $977 · 2022: $1,037 · 2023: $946 · 2024: $1,027 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,792.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,261.74 | 2019-2025 | Vraylar, Qulipta |
| Sanofi-Aventis U.S. LLC | $405.65 | 2019-2024 | |
| Lilly USA, LLC | $403.62 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $370.73 | 2019-2025 | Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $292.07 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $241.18 | 2019-2024 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $235.04 | 2019-2022 | |
| Astellas Pharma US INC | $222.72 | 2019-2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.52 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $212.02 | 2019-2025 | Rybelsus, Ozempic |
| Abbott Laboratories | $191.07 | 2021-2025 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $155.89 | 2023-2025 | Voquezna |
| Pfizer INC. | $151.13 | 2019-2025 | |
| Amarin Pharma, INC. | $132.32 | 2019-2022 | |
| Glaxosmithkline, LLC. | $123.58 | 2019-2025 | Shingrix, Arexvy |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $101.52 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $94.69 | 2019-2024 | Vaxelis, Gardasil 9, Rotateq |
| Boston Scientific Corporation | $84.38 | 2019-2025 | Wavewriter Alpha Prime 16, Watchman Flx, Watchman Access System |
| Supernus Pharmaceuticals, INC. | $78.77 | 2022-2025 | Qelbree, Qelbree |
| Biohaven Pharmaceuticals, INC. | $68.91 | 2021 | |
| Viatris Specialty LLC | $67.48 | 2025 | Yupelri |
| Amgen INC. | $65.53 | 2023-2024 | Repatha, Otezla |
| Edwards Lifesciences Corporation | $56.70 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Idorsia Pharmaceuticals US INC | $50.99 | 2023 | Quviviq |
| Aimmune Therapeutics, INC. | $50.53 | 2024-2025 | Zenpep |
| Sunovion Pharmaceuticals INC. | $50.17 | 2022 | |
| Cranial Technologies, INC | $49.07 | 2021-2025 | Doc Band |
| Nestle Healthcare Nutrition INC. | $46.73 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $41.43 | 2023 | Gemtesa |
| Shield Therapeutics INC | $39.27 | 2023 | Accrufer |
| Collegium Pharmaceutical, INC. | $38.32 | 2022-2024 | Belbuca |
| Dexcom, INC. | $35.92 | 2021-2025 | Dexcom G6 Transmitter |
| Organon LLC | $33.37 | 2021-2023 | Nexplanon |
| Gilead Sciences, INC. | $32.58 | 2019-2020 | |
| Corcept Therapeutics | $30.82 | 2024 | Korlym |
| Novartis Pharmaceuticals Corporation | $30.28 | 2022 | |
| Genentech USA, INC. | $26.45 | 2021 | |
| Neuronetics, INC. | $22.49 | 2025 | Neurostar Tms Therapy System |
| Urovant Sciences INC | $21.40 | 2022 | |
| Corium, LLC | $19.85 | 2023 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $18.74 | 2022 | |
| Axsome Therapeutics, INC. | $18.22 | 2024 | Sunosi |
| Ironshore Pharmaceuticals INC. | $17.57 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $16.88 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.85 | 2022 | |
| Medtronic, INC. | $16.42 | 2025 | Venaseal |
| Grifols USA, LLC | $15.65 | 2023 | Prolastin-C Liquid |
| C. R. Bard, INC. & Subsidiaries | $15.13 | 2024 | Bd Onclarity |
| Braintree Laboratories, INC. | $14.85 | 2019 | |
| Almatica Pharma LLC | $14.29 | 2023 | Loreev Xr |
| Radius Health, INC. | $14.25 | 2020 | |
| Antares Pharma, INC. | $13.57 | 2019 | |
| Dynavax Technologies Corporation | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.